Investigational drug may offer treatment for neuropathic pain of lupus and other diseases
Monday, April 30, 2012
A drug developed by Tel Aviv University researchers, known as BL-7050, may offer new hope to patients with neuropathic pain. The compound seems to inhibit the transmission of pain signals throughout the body. In early-stage testing measuring electrical activity of neurons, the compound has been shown to prevent the hyper-excitability of neurons -- protecting against neuropathic pain and epileptic seizures. The drug is expected to enter the first phase of clinical trials in upcoming months.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms